184 related articles for article (PubMed ID: 22846201)
1. SOX17 methylation inhibits its antagonism of Wnt signaling pathway in lung cancer.
Yin D; Jia Y; Yu Y; Brock MV; Herman JG; Han C; Su X; Liu Y; Guo M
Discov Med; 2012 Jul; 14(74):33-40. PubMed ID: 22846201
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic regulation of Wnt signaling pathway gene SRY-related HMG-box 17 in papillary thyroid carcinoma.
Li JY; Han C; Zheng LL; Guo MZ
Chin Med J (Engl); 2012 Oct; 125(19):3526-31. PubMed ID: 23044318
[TBL] [Abstract][Full Text] [Related]
3. Sox17, the canonical Wnt antagonist, is epigenetically inactivated by promoter methylation in human breast cancer.
Fu DY; Wang ZM; Li-Chen ; Wang BL; Shen ZZ; Huang W; Shao ZM
Breast Cancer Res Treat; 2010 Feb; 119(3):601-12. PubMed ID: 19301122
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of SOX17 by microRNA 141 and methylation activates the WNT signaling pathway in esophageal cancer.
Jia Y; Yang Y; Zhan Q; Brock MV; Zheng X; Yu Y; Herman JG; Guo M
J Mol Diagn; 2012 Nov; 14(6):577-85. PubMed ID: 22921431
[TBL] [Abstract][Full Text] [Related]
5. SOX17 restrains proliferation and tumor formation by down-regulating activity of the Wnt/β-catenin signaling pathway via trans-suppressing β-catenin in cervical cancer.
Li L; Yang WT; Zheng PS; Liu XF
Cell Death Dis; 2018 Jul; 9(7):741. PubMed ID: 29970906
[TBL] [Abstract][Full Text] [Related]
6. SOX17 antagonizes WNT/β-catenin signaling pathway in hepatocellular carcinoma.
Jia Y; Yang Y; Liu S; Herman JG; Lu F; Guo M
Epigenetics; 2010; 5(8):743-9. PubMed ID: 20716954
[TBL] [Abstract][Full Text] [Related]
7. Induction and down-regulation of Sox17 and its possible roles during the course of gastrointestinal tumorigenesis.
Du YC; Oshima H; Oguma K; Kitamura T; Itadani H; Fujimura T; Piao YS; Yoshimoto T; Minamoto T; Kotani H; Taketo MM; Oshima M
Gastroenterology; 2009 Oct; 137(4):1346-57. PubMed ID: 19549530
[TBL] [Abstract][Full Text] [Related]
8. SOX17 is a tumor suppressor in endometrial cancer.
Zhang Y; Bao W; Wang K; Lu W; Wang H; Tong H; Wan X
Oncotarget; 2016 Nov; 7(46):76036-76046. PubMed ID: 27738313
[TBL] [Abstract][Full Text] [Related]
9. Promoter methylation-mediated silencing of β-catenin enhances invasiveness of non-small cell lung cancer and predicts adverse prognosis.
Miao Y; Wang L; Zhang X; Xu X; Jiang G; Fan C; Liu Y; Lin X; Yu J; Zhang Y; Wang E
PLoS One; 2014; 9(11):e112258. PubMed ID: 25396757
[TBL] [Abstract][Full Text] [Related]
10. HOTAIR Knockdown Decreased the Activity Wnt/β-Catenin Signaling Pathway and Increased the mRNA Levels of Its Negative Regulators in Hela Cells.
Salmerón-Bárcenas EG; Illades-Aguiar B; Del Moral-Hernández O; Ortega-Soto A; Hernández-Sotelo D
Cell Physiol Biochem; 2019; 53(6):948-960. PubMed ID: 31820855
[TBL] [Abstract][Full Text] [Related]
11. SOX17 promoter methylation in plasma circulating tumor DNA of patients with non-small cell lung cancer.
Balgkouranidou I; Chimonidou M; Milaki G; Tsaroucha E; Kakolyris S; Georgoulias V; Lianidou E
Clin Chem Lab Med; 2016 Aug; 54(8):1385-93. PubMed ID: 26741346
[TBL] [Abstract][Full Text] [Related]
12. Modulation of the Wnt/beta-catenin pathway in human oligodendroglioma cells by Sox17 regulates proliferation and differentiation.
Chen HL; Chew LJ; Packer RJ; Gallo V
Cancer Lett; 2013 Jul; 335(2):361-71. PubMed ID: 23474492
[TBL] [Abstract][Full Text] [Related]
13. Wnt/β-catenin signalling regulates Sox17 expression and is essential for organizer and endoderm formation in the mouse.
Engert S; Burtscher I; Liao WP; Dulev S; Schotta G; Lickert H
Development; 2013 Aug; 140(15):3128-38. PubMed ID: 23824574
[TBL] [Abstract][Full Text] [Related]
14. Sox17 and β-catenin co-occupy Wnt-responsive enhancers to govern the endoderm gene regulatory network.
Mukherjee S; Chaturvedi P; Rankin SA; Fish MB; Wlizla M; Paraiso KD; MacDonald M; Chen X; Weirauch MT; Blitz IL; Cho KW; Zorn AM
Elife; 2020 Sep; 9():. PubMed ID: 32894225
[TBL] [Abstract][Full Text] [Related]
15. Sox17 modulates Wnt3A/beta-catenin-mediated transcriptional activation of the Lef-1 promoter.
Liu X; Luo M; Xie W; Wells JM; Goodheart MJ; Engelhardt JF
Am J Physiol Lung Cell Mol Physiol; 2010 Nov; 299(5):L694-710. PubMed ID: 20802155
[TBL] [Abstract][Full Text] [Related]
16. SOX17, β-catenin and CyclinD1 expression in the endometrioid adenocarcinoma and influence of 5-AZA on expression.
Liao YM; Song Y; Li YK; Du JH; Zhou Y
Cancer Gene Ther; 2020 Apr; 27(3-4):256-263. PubMed ID: 31543512
[TBL] [Abstract][Full Text] [Related]
17. A rapid and accurate closed-tube Methylation-Sensitive High Resolution Melting Analysis assay for the semi-quantitative determination of SOX17 promoter methylation in clinical samples.
Mastoraki S; Chimonidou M; Dimitrakopoulos L; Kounelis S; Malamos N; Georgoulias V; Lianidou E
Clin Chim Acta; 2015 Apr; 444():303-9. PubMed ID: 25727515
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic inactivation of the canonical Wnt antagonist SRY-box containing gene 17 in colorectal cancer.
Zhang W; Glöckner SC; Guo M; Machida EO; Wang DH; Easwaran H; Van Neste L; Herman JG; Schuebel KE; Watkins DN; Ahuja N; Baylin SB
Cancer Res; 2008 Apr; 68(8):2764-72. PubMed ID: 18413743
[TBL] [Abstract][Full Text] [Related]
19. Abnormal methylation of the sex-determining region Y-box 17 (SOX17) promoter predicts poor prognosis in myelodysplastic syndrome.
Fan R; Zhao XL; Wang H; He HY; Peng ZP; Yang B; Han T; Wang W; Wang XQ; Lin GW
Clin Lab; 2014; 60(9):1465-74. PubMed ID: 25291942
[TBL] [Abstract][Full Text] [Related]
20. Fine-Tuning of Sox17 and Canonical Wnt Coordinates the Permeability Properties of the Blood-Brain Barrier.
Corada M; Orsenigo F; Bhat GP; Conze LL; Breviario F; Cunha SI; Claesson-Welsh L; Beznoussenko GV; Mironov AA; Bacigaluppi M; Martino G; Pitulescu ME; Adams RH; Magnusson P; Dejana E
Circ Res; 2019 Feb; 124(4):511-525. PubMed ID: 30591003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
